Research Advances of Diagnostic Value of Magnetic Resonance Imaging in Dilated Cardiomyopathy_Journal of Biomedical Engineering

Authors：

WENLingyi ¹ , YANGZhigang ¹ ,  GUOYingkun ²

1. Department of Radiology, West China Hospital, Sichuan University, Chengdu 610041, China;
2. Department of Radiology, West China Second University Hospital, Sichuan University, Chengdu 610041, China;

Corresponding?author：

GUOYingkun, Email: gykpanda@163.com

Keywords：

dilated cardiomyopathy; magnetic resonance imaging; diagnosis

DOI：

10.7507/1001-5515.20160162

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Dilated cardiomyopathy (DCM) is a highly prevalent disease which has multiple clinical manifestations and pathological features. With the characteristics of multi-sequence and multi-parameter, cardiac magnetic resonance imaging (MRI) can accurately assess the morphology, function and tissue characterization of heart, and provide comprehensive information for diagnosis of DCM. This review focuses on the sequences and clinical applications of MRI evaluation in DCM in order to provide additional information for clinical diagnosis, treatment and prognosis.

Citation： WEN Lingyi, YANG Zhigang, GUO Yingkun. Research Advances of Diagnostic Value of Magnetic Resonance Imaging in Dilated Cardiomyopathy. Journal of Biomedical Engineering, 2016, 33(5): 1011-1015. doi: 10.7507/1001-5515.20160162 Copy

1.	GULATI A, JABBOUR A, ISMAIL T F, et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy[J]. JAMA, 2013, 309(9):896-908.
2.	HOFFMAN R, BARLETTA G, VON BARDELEBEN S, et al. Analysis of left ventricular volumes and function:a multicenter comparison of cardiac magnetic resonance imaging, cine ventriculography, and unenhanced and contrast-enhanced two-dimensional and three-dimensional echocardiography[J]. J Am Soc Echocardiogr, 2014, 27(3):292-301.
3.	MILLER C A, JORDAN P, BORG A, et al. Quantification of left ventricular indices from SSFP cine imaging:Impact of real-world variability in analysis methodology and utility of geometric modeling[J]. J Magn Reson Imaging, 2013, 37(5):1213-1222.
4.	EVERITT M D, SLEEPER L A, LU M, et al. Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy:results from the pediatric cardiomyopathy registry[J]. J Am Coll Cardiol, 2014, 63(14):1405-1413.
5.	HERSHBERGER R E, HEDGES D J, MORALES A. Dilated cardiomyopathy:the complexity of a diverse genetic architecture[J]. Nat Rev Cardiol, 2013, 10(9):531-547.
6.	MARON B J, TOWBIN J A, THIENE G, et al. Contemporary definitions and classification of the cardiomyopathies-An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; And Council on Epidemiology and Prevention[J]. Circulation, 2006, 113(14):1807-1816.
7.	HINSON J T, CHOPRA A, NAFISSI N, et al. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy[J]. Science, 2015, 349(6251):982-986.
8.	ELLIOTT P, ANDERSSON B, ARBUSTINI E, et al. Classification of the cardiomyopathies:a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases[J]. Eur Heart J, 2008, 29(2):270-276.
9.	GIESBRANDT K J, BOLAN C W, SHAPIRO B P, et al. Diffuse diseases of the myocardium:MRI-Pathologic review of nondilated cardiomyopathies[J]. American Journal of Roentgenology, 2013, 200(3):W266-W273.
10.	KIM J, KOCHAV J D, GUREVICH S, et al. Left ventricular geometric remodeling in relation to non-ischemic scar pattern on cardiac magnetic resonance imaging[J]. Int J Cardiovasc Imaging, 2014, 30(8):1559-1567.
11.	DONEKAL S, VENKATESH B A, LIU Y C, et al. Interstitial fibrosis, left ventricular remodeling, and myocardial mechanical behavior in a population-based multiethnic cohort:the Multi-Ethnic Study of Atherosclerosis(Mesa)study[J]. Circ Cardiovasc Imaging, 2014, 7(2):292-302.
12.	DHARMAKUMAR R, SHARIF B, YANG H J. Basic principles of cardiovascular MRI[M]. Switzerland:Springer, 2015:25-40.
13.	趙世華, 蔣世良, 陸敏杰.心血管病磁共振診斷學[M].北京:人民軍醫出版社, 2011:19-40.
14.	RAJIAH P, BOLEN M. Cardiovascular MR imaging at 3 T:opportunities, challenges, and solutions[J].Radiographics, 2014, 34(6):1612-1635.
15.	AMBALE-VENKATESH B, LIMA J A. Cardiac MRI:a central prognostic tool in myocardial fibrosis[J]. Nat Rev Cardiol, 2015, 12(1):18-29.
16.	SYHA R, KETELSEN D, KAEMPF M, et al. In vitro stent lumen visualisation of various common and newly developed femoral artery stents using MR angiography at 1.5 and 3 tesla[J]. Eur Radiol, 2013, 23(2):588-595.
17.	FERREIRA V M, PIECHNIK S K, ROBSON M D, et al. Myocardial tissue characterization by magnetic resonance imaging novel applications of T1 and T2 mapping[J]. J Thorac Imaging, 2014, 29(3):147-154.
18.	SALERNO M, KRAMER C M. Advances in parametric mapping with CMR imaging[J]. JACC Cardiovasc Imaging, 2013, 6(7):806-822.
19.	FOELL D, JUNG B A, GERMANN E, et al. Segmental myocardial velocities in dilated cardiomyopathy with and without left bundle branch block[J]. Journal of Magnetic Resonance Imaging, 2013, 37(1):119-126.
20.	MCCROHON A, MOON J C, PRASAD S K, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance[J]. Circulation, 2003, 108(1):54-59.
21.	MOON J C, MESSROGHLI D R, KELLMAN P, et al. Myocardial T1 mapping and extracellular volume quantification:a Society for Cardiovascular Magnetic Resonance(SCMR)and CMR Working Group of the European Society of Cardiology consensus statement[J]. J Cardiovasc Magn Reson, 2013, 15:92.
22.	DASS S, SUTTIE J J, PIECHNIK S K, et al. Myocardial tissue characterization using magnetic resonance noncontrast T1 mapping in hypertrophic and dilated cardiomyopathy[J]. Circ Cardiovasc Imaging, 2012, 5(6):726-733.
23.	MORDI I, CARRICK D, BEZERRA H. T1 and T2 mapping for early diagnosis of dilated non-ischaemic cardiomyopathy in middle-aged patients and differentiation from normal physiological adaptation[J]. Eur Heart J Cardiovasc Imaging, 2016, 17(7):797-803.
24.	PUNTMANN V O, VOIGT T, CHEN Zhong, et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy[J]. JACC Cardiovasc Imaging, 2013, 6(4):475-484.
25.	NISHII T, KONO A K, SHIGERU M, et al. Cardiovascular magnetic resonance T2 mapping can detect myocardial edema in idiopathic dilated cardiomyopathy[J]. Int J Cardiovasc Imaging, 2014, 30(1):65-72.
26.	CARPENTER J P, GRASSO A E, PORTER J B, et al. On myocardial siderosis and left ventricular dysfunction in hemochromatosis[J]. J Cardiovasc Magn Reson, 2013, 15:24.

1. GULATI A, JABBOUR A, ISMAIL T F, et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy[J]. JAMA, 2013, 309(9):896-908.
2. HOFFMAN R, BARLETTA G, VON BARDELEBEN S, et al. Analysis of left ventricular volumes and function:a multicenter comparison of cardiac magnetic resonance imaging, cine ventriculography, and unenhanced and contrast-enhanced two-dimensional and three-dimensional echocardiography[J]. J Am Soc Echocardiogr, 2014, 27(3):292-301.
3. MILLER C A, JORDAN P, BORG A, et al. Quantification of left ventricular indices from SSFP cine imaging:Impact of real-world variability in analysis methodology and utility of geometric modeling[J]. J Magn Reson Imaging, 2013, 37(5):1213-1222.
4. EVERITT M D, SLEEPER L A, LU M, et al. Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy:results from the pediatric cardiomyopathy registry[J]. J Am Coll Cardiol, 2014, 63(14):1405-1413.
5. HERSHBERGER R E, HEDGES D J, MORALES A. Dilated cardiomyopathy:the complexity of a diverse genetic architecture[J]. Nat Rev Cardiol, 2013, 10(9):531-547.
6. MARON B J, TOWBIN J A, THIENE G, et al. Contemporary definitions and classification of the cardiomyopathies-An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; And Council on Epidemiology and Prevention[J]. Circulation, 2006, 113(14):1807-1816.
7. HINSON J T, CHOPRA A, NAFISSI N, et al. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy[J]. Science, 2015, 349(6251):982-986.
8. ELLIOTT P, ANDERSSON B, ARBUSTINI E, et al. Classification of the cardiomyopathies:a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases[J]. Eur Heart J, 2008, 29(2):270-276.
9. GIESBRANDT K J, BOLAN C W, SHAPIRO B P, et al. Diffuse diseases of the myocardium:MRI-Pathologic review of nondilated cardiomyopathies[J]. American Journal of Roentgenology, 2013, 200(3):W266-W273.
10. KIM J, KOCHAV J D, GUREVICH S, et al. Left ventricular geometric remodeling in relation to non-ischemic scar pattern on cardiac magnetic resonance imaging[J]. Int J Cardiovasc Imaging, 2014, 30(8):1559-1567.
11. DONEKAL S, VENKATESH B A, LIU Y C, et al. Interstitial fibrosis, left ventricular remodeling, and myocardial mechanical behavior in a population-based multiethnic cohort:the Multi-Ethnic Study of Atherosclerosis(Mesa)study[J]. Circ Cardiovasc Imaging, 2014, 7(2):292-302.
12. DHARMAKUMAR R, SHARIF B, YANG H J. Basic principles of cardiovascular MRI[M]. Switzerland:Springer, 2015:25-40.
13. 趙世華, 蔣世良, 陸敏杰.心血管病磁共振診斷學[M].北京:人民軍醫出版社, 2011:19-40.
14. RAJIAH P, BOLEN M. Cardiovascular MR imaging at 3 T:opportunities, challenges, and solutions[J].Radiographics, 2014, 34(6):1612-1635.
15. AMBALE-VENKATESH B, LIMA J A. Cardiac MRI:a central prognostic tool in myocardial fibrosis[J]. Nat Rev Cardiol, 2015, 12(1):18-29.
16. SYHA R, KETELSEN D, KAEMPF M, et al. In vitro stent lumen visualisation of various common and newly developed femoral artery stents using MR angiography at 1.5 and 3 tesla[J]. Eur Radiol, 2013, 23(2):588-595.
17. FERREIRA V M, PIECHNIK S K, ROBSON M D, et al. Myocardial tissue characterization by magnetic resonance imaging novel applications of T1 and T2 mapping[J]. J Thorac Imaging, 2014, 29(3):147-154.
18. SALERNO M, KRAMER C M. Advances in parametric mapping with CMR imaging[J]. JACC Cardiovasc Imaging, 2013, 6(7):806-822.
19. FOELL D, JUNG B A, GERMANN E, et al. Segmental myocardial velocities in dilated cardiomyopathy with and without left bundle branch block[J]. Journal of Magnetic Resonance Imaging, 2013, 37(1):119-126.
20. MCCROHON A, MOON J C, PRASAD S K, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance[J]. Circulation, 2003, 108(1):54-59.
21. MOON J C, MESSROGHLI D R, KELLMAN P, et al. Myocardial T1 mapping and extracellular volume quantification:a Society for Cardiovascular Magnetic Resonance(SCMR)and CMR Working Group of the European Society of Cardiology consensus statement[J]. J Cardiovasc Magn Reson, 2013, 15:92.
22. DASS S, SUTTIE J J, PIECHNIK S K, et al. Myocardial tissue characterization using magnetic resonance noncontrast T1 mapping in hypertrophic and dilated cardiomyopathy[J]. Circ Cardiovasc Imaging, 2012, 5(6):726-733.
23. MORDI I, CARRICK D, BEZERRA H. T1 and T2 mapping for early diagnosis of dilated non-ischaemic cardiomyopathy in middle-aged patients and differentiation from normal physiological adaptation[J]. Eur Heart J Cardiovasc Imaging, 2016, 17(7):797-803.
24. PUNTMANN V O, VOIGT T, CHEN Zhong, et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy[J]. JACC Cardiovasc Imaging, 2013, 6(4):475-484.
25. NISHII T, KONO A K, SHIGERU M, et al. Cardiovascular magnetic resonance T2 mapping can detect myocardial edema in idiopathic dilated cardiomyopathy[J]. Int J Cardiovasc Imaging, 2014, 30(1):65-72.
26. CARPENTER J P, GRASSO A E, PORTER J B, et al. On myocardial siderosis and left ventricular dysfunction in hemochromatosis[J]. J Cardiovasc Magn Reson, 2013, 15:24.

Previous Article
Effect of Lysophosphatidic Acid on Cell Migration and Its Relative Molecular Mechanisms
Next Article
Research Progress of Micro-arc Oxidation Surface Treatment of Magnesium Alloy

Journal of Biomedical Engineering

Research Advances of Diagnostic Value of Magnetic Resonance Imaging in Dilated Cardiomyopathy

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content